THE CLINIK MEDICAL GUIDE™ · EPIGEN-IQ

Peptides, Biohacking & Investigational Compounds

Not every compound in this guide is a peptide. Some are medicines with specific indications; many are experimental substances. Inclusion does not mean THE CLINIK offers, prescribes or recommends them.

Educational content only. This is not medical advice or a recommendation to purchase, prepare or administer any substance. Approval and availability vary by country and formulation. Subject to editorial clinical review.

CJC-1295 and ipamorelin

Growth-hormone secretagogues

What is being studied?

Investigated for effects on growth hormone and IGF-1 signaling. Long-term safety for anti-aging or muscle gain has not been established.

Limitations and precautions

May affect blood glucose, cause fluid retention and other adverse effects. Formulation and regulatory status matter.

BPC-157

Experimental tissue-repair peptide

What is being studied?

Studied mainly in preclinical models of tissue repair. Robust human clinical evidence for muscle, tendon or gastrointestinal benefits is lacking.

Limitations and precautions

Long-term risks, product quality and safety of many preparations are unknown.

TB-500

Experimental thymosin beta-4-related peptide

What is being studied?

Investigated in relation to tissue repair and cell migration; human clinical evidence for TB-500 is very limited.

Limitations and precautions

Should not be presented as a proven tendon or sports-recovery treatment.

GHK-Cu

Copper peptide; dermatology research

What is being studied?

Studied in skin care and repair; evidence depends on formulation and route.

Limitations and precautions

Topical cosmetic evidence cannot be assumed to establish injectable safety or effectiveness.

AOD-9604

Experimental growth-hormone-related fragment

What is being studied?

Studied for potential fat-metabolism effects, without sufficient evidence to recommend it as an effective obesity treatment.

Limitations and precautions

It is not equivalent to approved weight-management medications.

NAD+

Metabolic coenzyme; not a peptide

What is being studied?

Involved in cellular energy and repair pathways. NAD+-raising interventions are under investigation for aging and metabolism.

Limitations and precautions

Infusions and supplements have not been shown to reverse aging.

Glutathione

Endogenous antioxidant; tripeptide

What is being studied?

Involved in antioxidant defense and cellular metabolism. Different formulations have been studied for specific conditions.

Limitations and precautions

Broad detoxification or skin-lightening promises are not consistently supported; risks differ by route.

Kisspeptin-10

Reproductive signaling peptide

What is being studied?

Investigated for its role in the hypothalamic-pituitary-gonadal axis and reproductive hormone release.

Limitations and precautions

Not a generally proven treatment to improve fertility, libido or testosterone.

PT-141 (bremelanotide)

Melanocortin receptor agonist

What is being studied?

Bremelanotide is approved for a specific sexual-health indication in certain countries and populations; other uses are not established.

Limitations and precautions

Can cause nausea and transient blood-pressure changes; indications and availability vary by country.

Selank

Investigational neuroactive peptide

What is being studied?

Studied for possible anxiety-related and neurobiological effects, with limited internationally accepted clinical evidence.

Limitations and precautions

Does not replace validated treatments for anxiety disorders.

Semax

Investigational neuroactive peptide

What is being studied?

Investigated in neurological and cognitive settings; evidence for widespread use is limited.

Limitations and precautions

Not proven to be a safe cognitive enhancer for healthy individuals.

KPV

Experimental tripeptide

What is being studied?

Investigated for possible anti-inflammatory effects in preclinical skin and intestinal models.

Limitations and precautions

Insufficient evidence for routine clinical treatment.

SLU-PP-332

Experimental compound; not a peptide

What is being studied?

Experimental ERR receptor agonist studied in animals for metabolic and exercise-related effects.

Limitations and precautions

Not an approved medicine; adequate human safety and efficacy evidence is lacking.

5-Amino-1MQ

Experimental small molecule; not a peptide

What is being studied?

Experimental NNMT inhibitor studied primarily in preclinical metabolic research.

Limitations and precautions

Insufficient human clinical evidence to recommend it for weight loss.

MOTS-c

Experimental mitochondrial peptide

What is being studied?

Investigated for links to metabolic signaling and exercise response.

Limitations and precautions

Human evidence is preliminary; not established as a longevity treatment.

Tesamorelin

GHRH analog

What is being studied?

Has a specific authorized indication in some countries for HIV-associated visceral fat reduction; it is not a general weight-loss drug.

Limitations and precautions

May affect glucose and IGF-1 and requires clinical assessment and monitoring.

Epitalon

Experimental longevity peptide

What is being studied?

Investigated in preclinical and limited aging-related research.

Limitations and precautions

Robust clinical evidence of lifespan extension in humans is lacking.

DSIP

Experimental sleep-related peptide

What is being studied?

Studied for possible connections with sleep regulation, with limited and inconsistent results.

Limitations and precautions

Not a standard insomnia treatment.

Before considering any treatment

Preclinical findings do not establish safety or efficacy in humans. Unapproved substances, particularly injectables, may present quality, contamination, uncertain-dose and unknown adverse-effect risks. Each option requires individualized medical assessment.

Request a personal consultation